Combination of Clinical and Neuropsychologic Information as a Better Predictor of the Progression to Alzheimer Disease in Questionable Dementia Individuals
- 1 February 2006
- journal article
- research article
- Published by Elsevier in The American Journal of Geriatric Psychiatry
- Vol. 14 (2) , 130-138
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Premorbid cognitive testing predicts the onset of dementia and Alzheimer's disease better than and independently of APOE genotypeJournal of Neurology, Neurosurgery & Psychiatry, 2004
- A normative study of the CERAD neuropsychological assessment battery in the Korean elderlyJournal of the International Neuropsychological Society, 2004
- Utility of the Apolipoprotein E Genotype in the Diagnosis of Alzheimer's DiseaseNew England Journal of Medicine, 1998
- Cerebrovascular Disease, the Apolipoprotein e4 Allele, and Cognitive Decline in a Community-Based Study of Elderly MenStroke, 1996
- Apolipoprotein E and cognitive change in an elderly populationAnnals of Neurology, 1996
- A prospective study of the clinical utility of ApoE genotype in the prediction of outcome in patients with memory impairmentNeurology, 1996
- Neuropsychological prediction of dementia and the absence of dementia in healthy elderly personsNeurology, 1994
- The Clinical Dementia Rating (CDR)Neurology, 1993
- Vascular dementiaNeurology, 1993
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984